{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:08:00Z","timestamp":1791205680083,"version":"4.1.0"},"reference-count":185,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T00:00:00Z","timestamp":1427068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:p>Objective: To review the oral and injectable pharmacologic treatment options for type 2 diabetes. Data Sources: A literature search was conducted using PubMed electronic database for studies published in English between 1993 and September 2014. Search terms included diabetes mellitus, type 2 diabetes, and the individual name for each antidiabetic medication reviewed. In addition, manual searches were performed for cross-references from publications. Package inserts, United States Food and Drug Administration (FDA) Web site, Institute for Safe Medication Practices Web site, American Diabetes Association Web site and scientific session poster presentations, and individual drug company Web pages were also reviewed. Study Selection and Data Extraction: This review focused on information elucidated over the past 10 years to assist prescribers in choosing optimal therapy based on individual patient characteristics. Studies leading to the approval of or raising safety concerns for the antidiabetic medications reviewed in this article were included. Data Synthesis: In the past 10 years, there have been 4 novel oral antidiabetic medication classes and 10 new injectable agents and insulin products approved by the FDA for the treatment of type 2 diabetes as well as new information regarding the safety and use of several older antidiabetic medication classes. The distinctions were reviewed for each individual agent, and a comparison was completed if there was more than one agent in a particular therapeutic class. Using current information available, select investigational agents in phase III trials or with a pending new drug application were highlighted. Conclusion: There are now 9 distinct oral pharmacologic classes and a variety of insulin and noninsulin injectable medications available for the treatment of type 2 diabetes. Metformin remains the first-line treatment option for most patients. When considering options for alternative or additional treatment, prescribers must weigh the benefits and risks using individual patient characteristics.<\/jats:p>","DOI":"10.1177\/1060028015573010","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T22:51:58Z","timestamp":1427151118000},"page":"700-714","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacologic Treatment of Type 2 Diabetes"],"prefix":"10.1177","volume":"49","author":[{"given":"Linda","family":"Tran","sequence":"first","affiliation":[{"name":"Chalmers P. Wylie Veterans Affairs Ambulatory Care Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zielinski","sequence":"additional","affiliation":[{"name":"Chalmers P. Wylie Veterans Affairs Ambulatory Care Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpi H.","family":"Roach","sequence":"additional","affiliation":[{"name":"Chalmers P. Wylie Veterans Affairs Ambulatory Care Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Jende","sequence":"additional","affiliation":[{"name":"Chalmers P. Wylie Veterans Affairs Ambulatory Care Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Householder","sequence":"additional","affiliation":[{"name":"Chalmers P. Wylie Veterans Affairs Ambulatory Care Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Cole","sequence":"additional","affiliation":[{"name":"Chalmers P. Wylie Veterans Affairs Ambulatory Care Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuruq A.","family":"Atway","sequence":"additional","affiliation":[{"name":"Chalmers P. Wylie Veterans Affairs Ambulatory Care Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Amornyard","sequence":"additional","affiliation":[{"name":"Chalmers P. Wylie Veterans Affairs Ambulatory Care Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory L.","family":"Accursi","sequence":"additional","affiliation":[{"name":"Chalmers P. Wylie Veterans Affairs Ambulatory Care Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanna W.","family":"Shieh","sequence":"additional","affiliation":[{"name":"Chalmers P. Wylie Veterans Affairs Ambulatory Care Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Chalmers P. Wylie Veterans Affairs Ambulatory Care Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2015,3,23]]},"reference":[{"key":"bibr1-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"bibr2-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"bibr3-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60576-4"},{"key":"bibr4-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808431"},{"key":"bibr5-1060028015573010","unstructured":"FDA-Approved Diabetes Medicines. http:\/\/www.fda.gov\/forpatients\/illness\/diabetes\/ucm408682.htm. Accessed October 23, 2014."},{"key":"bibr6-1060028015573010","unstructured":"FDA News Release: FDA approves Afrezza to treat diabetes. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm403122.htm. Accessed July 13, 2014."},{"key":"bibr7-1060028015573010","unstructured":"FDA News Release: FDA approves Tanzeum to treat type 2 diabetes. http:\/\/www.fda.gov\/newsevents\/newsroom\/pressanno-uncements\/ucm393289.htm. Accessed July 20, 2014."},{"key":"bibr8-1060028015573010","unstructured":"Trulicity (dulaglutide) [product information]. Indianapolis, IN: Eli-Lilly, Bridgewater; 2014."},{"key":"bibr9-1060028015573010","unstructured":"SymlinPen (pramlintide) [product information]. Wilmington, DE: AstraZeneca; 2014."},{"key":"bibr10-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.3.784"},{"key":"bibr11-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2003.00295.x"},{"key":"bibr12-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2006.0013"},{"key":"bibr13-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0589"},{"key":"bibr14-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01201.x"},{"key":"bibr15-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00034.2006"},{"key":"bibr16-1060028015573010","unstructured":"Byetta (exenatide) injection [product information]. Princeton, NJ: Bristol-Myers Squib Co; 2013."},{"key":"bibr17-1060028015573010","unstructured":"Victoza (liraglutide) injection [product information]. Plainsboro, NJ: NovoNordisk; 2013."},{"key":"bibr18-1060028015573010","unstructured":"Bydureon (exenatide kit) [product information]. Princeton, NJ: Bristol-Myers Squib Co; 2013."},{"key":"bibr19-1060028015573010","unstructured":"Tanzeum (albiglutide) injection [product information]. Wilmington, DE: GlaxoSmithKline LLC; 2014."},{"key":"bibr20-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01364.x"},{"key":"bibr21-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2760"},{"key":"bibr22-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2759"},{"key":"bibr23-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2761"},{"key":"bibr24-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/j\/clinthera.2008.08.006"},{"key":"bibr25-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61246-5"},{"key":"bibr26-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1107\/-\/DC1"},{"key":"bibr27-1060028015573010","first-page":"S360","volume":"56","author":"Reinhardt R","year":"2013","journal-title":"Diabetologia"},{"key":"bibr28-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1092"},{"key":"bibr29-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.11.2628"},{"key":"bibr30-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1083"},{"key":"bibr31-1060028015573010","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-7-200704030-00003"},{"key":"bibr32-1060028015573010","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-8-200510180-00006"},{"key":"bibr33-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.11.006"},{"key":"bibr34-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2009.0266.x"},{"key":"bibr35-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1355"},{"key":"bibr36-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1472-y"},{"key":"bibr37-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-2124"},{"key":"bibr38-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60659"},{"key":"bibr39-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60307-8"},{"key":"bibr40-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61267-7"},{"key":"bibr41-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61206-4"},{"key":"bibr42-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-636(10)60590-9"},{"key":"bibr43-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60406-0"},{"key":"bibr44-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1210\/jc\/2010-2081"},{"key":"bibr45-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2375"},{"key":"bibr46-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0024"},{"key":"bibr47-1060028015573010","first-page":"S360","volume":"56","author":"Pratley R","year":"2013","journal-title":"Diabetologia"},{"key":"bibr48-1060028015573010","first-page":"S361","volume":"56","author":"Stewart M","year":"2013","journal-title":"Diabetologia"},{"key":"bibr49-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70214-6"},{"key":"bibr50-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.SS3075"},{"key":"bibr51-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2855"},{"key":"bibr52-1060028015573010","volume-title":"Paper presented at: 74th Scientific Session American Diabetes Association","author":"Giorgino F"},{"key":"bibr53-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0001"},{"key":"bibr54-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0510-2"},{"key":"bibr55-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1914"},{"key":"bibr56-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60976-4"},{"key":"bibr57-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0366"},{"key":"bibr58-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12012"},{"key":"bibr59-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X253870"},{"key":"bibr60-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-2260"},{"key":"bibr61-1060028015573010","doi-asserted-by":"publisher","DOI":"10.118\/1472-6823-11-9"},{"key":"bibr62-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S35801"},{"key":"bibr63-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1233"},{"key":"bibr64-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.018"},{"key":"bibr65-1060028015573010","unstructured":"Parola T. Victoza (liraglutide injections): human relevance of rodent thyroid C-cell tumors. Endocrinologic and Metabolic Drugs Advisory Committee Meeting. http:\/\/www.fda.gov\/downloads\/advisorycommittees\/committeesmeetingmaterials\/drugs\/endocrinologicandmetabolicdrugsadvisorycommittee\/ucm151129.pdf. Accessed March 15, 2014."},{"key":"bibr66-1060028015573010","unstructured":"FDA Drug Safety Communication. FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm343187.htm. Accessed March 16, 2014."},{"key":"bibr67-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01231.x"},{"key":"bibr68-1060028015573010","unstructured":"European Medicines Agency. Investigation into GLP-1 based diabetes therapies concluded. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2013\/07\/news_detail_001856.jsp&mid=WC0b01ac058004d5c1. Accessed August 18, 2014."},{"key":"bibr69-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1314078"},{"key":"bibr70-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1177\/2042098612454290"},{"key":"bibr71-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/215764"},{"key":"bibr72-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12251"},{"key":"bibr73-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12175"},{"key":"bibr74-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.07.012"},{"key":"bibr75-1060028015573010","unstructured":"Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial to evaluate cardiovascular outcomes after treatment with exenatide once weekly in patients with type 2 diabetes mellitus. http:\/\/clinicaltrials.gov\/show\/NCT01144338. Accessed March 11, 2014."},{"key":"bibr76-1060028015573010","unstructured":"Lantus (insulin glargine) injection [product information]. Bridgewater, NJ: Sanofi-Aventis; 2013."},{"key":"bibr77-1060028015573010","unstructured":"Levmir (insulin detemir) injection [product information]. Bagsvaerd, Denmark: Novo Nordisk; 2013."},{"key":"bibr78-1060028015573010","unstructured":"Humulin (insulin regular U-500 concentrated) injection [product information]. Indianapolis, IN: Lilly USA; 2013."},{"key":"bibr79-1060028015573010","unstructured":"Humulin N (human insulin [rDNA origin] isophane suspension) injection [product information]. Indianapolis, IN: Lilly USA; 2013."},{"key":"bibr80-1060028015573010","unstructured":"Novolin N (NPH, human insulin isophane suspension [recombinant DNA origin]) injection [product information]. Bagsvaerd, Denmark: Novo Nordisk; 2013."},{"key":"bibr81-1060028015573010","unstructured":"Humulin (insulin regular) injection [product information]. Indianapolis, IN: Lilly USA; 2013."},{"key":"bibr82-1060028015573010","unstructured":"Novolin (insulin regular) injection [product information]. Bagsvaerd, Denmark: Novo Nordisk; 2013."},{"key":"bibr83-1060028015573010","unstructured":"Novolog (insulin aspart) injection [product information]. Plainsboro, NJ: Novo Nordisk; 2014."},{"key":"bibr84-1060028015573010","unstructured":"Humalog (insulin lispro) injection [product information]. Indianapolis, IN: Eli Lilly & Company; 2013."},{"key":"bibr85-1060028015573010","unstructured":"Apidra (insulin glulisine injection) [product information]. Bridgewater, NJ: Sanofi-Aventis; 2014."},{"key":"bibr86-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1107"},{"key":"bibr87-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.11.001"},{"key":"bibr88-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.989"},{"key":"bibr89-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0911-x"},{"key":"bibr90-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-2294"},{"key":"bibr91-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006383.pub2"},{"key":"bibr92-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1159\/000149569"},{"key":"bibr93-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051172"},{"key":"bibr94-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1079\/BJN20051592"},{"key":"bibr95-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2005.00567.x"},{"key":"bibr96-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1418-4"},{"key":"bibr97-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1444-2"},{"key":"bibr98-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1440-6"},{"key":"bibr99-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0506"},{"key":"bibr100-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-9025"},{"key":"bibr101-1060028015573010","unstructured":"Food and Drug Administration. FDA drug safety communication: update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm239376.htm. Accessed February 24, 2014."},{"key":"bibr102-1060028015573010","unstructured":"European Medicines Agency. Outcomes of review of new safety data on insulin glargine. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Medicine_QA\/2013\/05\/WC500143823.pdf. Accessed March 16, 2014."},{"key":"bibr103-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.11.3080"},{"key":"bibr104-1060028015573010","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.78a.10051"},{"key":"bibr105-1060028015573010","first-page":"183","volume":"84","author":"Petznick A","year":"2011","journal-title":"Am Fam Physician"},{"key":"bibr106-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.6.1738"},{"key":"bibr107-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-39080"},{"key":"bibr108-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0132-0"},{"key":"bibr109-1060028015573010","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-12-200306170-00006"},{"key":"bibr110-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.4.631"},{"key":"bibr111-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2005.10.015"},{"key":"bibr112-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12329"},{"key":"bibr113-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00804.x"},{"key":"bibr114-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01881.x"},{"key":"bibr115-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.6.1282"},{"key":"bibr116-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1357"},{"key":"bibr117-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-1365"},{"key":"bibr118-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.2.254"},{"key":"bibr119-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.01.06.dc05-1058"},{"key":"bibr120-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa075392"},{"key":"bibr121-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905479"},{"key":"bibr122-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2137"},{"key":"bibr123-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.08.007"},{"key":"bibr124-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2009.01060.x"},{"key":"bibr125-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2008.00915.x"},{"key":"bibr126-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-2191"},{"key":"bibr127-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1177\/193229680700100412"},{"key":"bibr128-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2014.04.003"},{"key":"bibr129-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-973082"},{"key":"bibr130-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2004.00373.x"},{"key":"bibr131-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2004.03.003"},{"key":"bibr132-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.081041"},{"key":"bibr133-1060028015573010","doi-asserted-by":"publisher","DOI":"10.3310\/hta14360"},{"issue":"2","key":"bibr134-1060028015573010","first-page":"CD005613","author":"Horvath K","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr135-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0721"},{"key":"bibr136-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(00)00196-0"},{"key":"bibr137-1060028015573010","doi-asserted-by":"publisher","DOI":"10.4158\/EP.15.1.71"},{"key":"bibr138-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S1557-0843(08)80049-8"},{"key":"bibr139-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1240"},{"key":"bibr140-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1490"},{"key":"bibr141-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1478"},{"key":"bibr142-1060028015573010","doi-asserted-by":"publisher","DOI":"10.4158\/EP.11.5.305"},{"key":"bibr143-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.02.012"},{"key":"bibr144-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1592\/phco.31.7.695"},{"key":"bibr145-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.1480"},{"key":"bibr146-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1148"},{"key":"bibr147-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1177\/193229681200600229"},{"key":"bibr148-1060028015573010","doi-asserted-by":"publisher","DOI":"10.4158\/EP12226.OR"},{"key":"bibr149-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1177\/0897190013516505"},{"key":"bibr150-1060028015573010","unstructured":"Institute for Safe Medication Practices. Extra caution needed with U-500 insulin: ISMP medication safety alert! http:\/\/www.ismp.org\/newsletters\/acutecare\/articles\/19970129.asp. Accessed October 9, 2014."},{"key":"bibr151-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.709"},{"key":"bibr152-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-010-0167-6"},{"key":"bibr153-1060028015573010","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2013.772059"},{"key":"bibr154-1060028015573010","doi-asserted-by":"publisher","DOI":"10.4158\/EP13407.OR"},{"key":"bibr155-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-S319"},{"key":"bibr156-1060028015573010","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2012.699715"},{"key":"bibr157-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.1339"},{"key":"bibr158-1060028015573010","doi-asserted-by":"publisher","DOI":"10.4158\/EP13210"},{"key":"bibr159-1060028015573010","first-page":"2266","volume":"17","author":"Dewitt DE","year":"2003","journal-title":"JAMA"},{"key":"bibr160-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S26889"},{"key":"bibr161-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.9.1501"},{"key":"bibr162-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01473.x"},{"key":"bibr163-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(97)80091-4"},{"key":"bibr164-1060028015573010","first-page":"292","volume":"24","author":"Ross SA","year":"2001","journal-title":"Clin Invest Med"},{"key":"bibr165-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.10.2363"},{"issue":"2","key":"bibr166-1060028015573010","first-page":"CD003287","author":"Plank J","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr167-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2009.01039.x"},{"key":"bibr168-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60632-0"},{"key":"bibr169-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01500"},{"key":"bibr170-1060028015573010","unstructured":"Afrezza (insulin human) inhalation powder [product information]. Danbury, CT: MannKind Corporation; 2014."},{"key":"bibr171-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12019"},{"key":"bibr172-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2011.0001"},{"key":"bibr173-1060028015573010","unstructured":"Novolog 70\/30 (insulin aspart) [product information]. Plainsboro, NJ: Novo Nordisk; 2010."},{"key":"bibr174-1060028015573010","unstructured":"Humalog 50\/50 (insulin lispro) [product information]. Indianapolis, IN: Eli Lilly & Company; 2010."},{"key":"bibr175-1060028015573010","unstructured":"Humalog 75\/25 (insulin lispro) [product information]. Indianapolis, IN: Eli Lilly & Company; 2013."},{"key":"bibr176-1060028015573010","unstructured":"Novolin 70\/30 (insulin NPH\/regular) [product information]. Plainsboro, NJ: Novo Nordisk; 2013."},{"key":"bibr177-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1710"},{"key":"bibr178-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01638"},{"key":"bibr179-1060028015573010","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12303"},{"key":"bibr180-1060028015573010","unstructured":"Novo Nordisk. Novo Nordisk receives complete response letter in the US for Tresiba\u00ae and Ryzodeg\u00ae. http:\/\/www.novonordisk.com\/include\/asp\/exe_news_attachment.asp?sAttachmentGUID=83700060-0ce3-4577-a35a-f3e57801637d. Accessed March 13, 2014."},{"key":"bibr181-1060028015573010","first-page":"A1029","volume":"56","author":"Jax T","year":"2013","journal-title":"Diabetologia"},{"key":"bibr182-1060028015573010","first-page":"A220","volume":"56","author":"Riddle MC","year":"2013","journal-title":"Diabetologia"},{"key":"bibr183-1060028015573010","volume-title":"Paper presented at: 74th Scientific Session, American Diabetes Association","author":"Ritzel R"},{"key":"bibr184-1060028015573010","unstructured":"Toujeo (insulin glargine U-300) injection [product information]. Bridgewater, NJ: Sanofi-Aventis; 2015"},{"key":"bibr185-1060028015573010","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2441"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1060028015573010","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1060028015573010","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1060028015573010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:15:42Z","timestamp":1777374942000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1060028015573010"}},"subtitle":["Injectable Medications"],"short-title":[],"issued":{"date-parts":[[2015,3,23]]},"references-count":185,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1177\/1060028015573010"],"URL":"https:\/\/doi.org\/10.1177\/1060028015573010","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,23]]}}}